Ligand Pharmaceuticals
LGND
#3617
Rank
C$5.15 B
Marketcap
C$261.75
Share price
-1.57%
Change (1 day)
54.98%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2025 (TTM): C$88.66 Million

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are C$0.25 Billion. In 2024 the company made an earning of C$7.56 Million a decrease over its 2023 earnings that were of C$87.63 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$88.66 M1072.31%
2024 C$7.56 M-91.37%
2023 C$87.63 M-7.59%
2022 C$94.83 M4%
2021 C$91.18 M296.42%
2020 C$23 M-97.97%
2019 C$1.13 B275.62%
2018 C$0.30 B237.48%
2017 C$89.47 M49.05%
2016 C$60.02 M55.41%
2015 C$38.62 M36.87%
2014 C$28.21 M29.59%
2013 C$21.77 M1309.35%
2012 C$1.54 M-43.97%
2011 C$2.75 M-113.19%
2010 -C$20.91 Million59.86%
2009 -C$13.08 Million-61.33%
2008 -C$33.83 Million-58.75%
2007 -C$82 Million20.52%
2006 -C$68.04 Million81.27%
2005 -C$37.54 Million
2003 -C$26.13 Million-20.6%
2002 -C$32.91 Million4.38%
2001 -C$31.53 Million-48.83%
2000 -C$61.61 Million-19.74%
1999 -C$76.76 Million-19.06%
1998 -C$94.84 Million126.71%
1997 -C$41.84 Million-5.83%
1996 -C$44.42 Million136.23%
1995 -C$18.81 Million-33.97%
1994 -C$28.48 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$44.14 B 48,402.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$16.14 B 17,644.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$30.66 B 33,591.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$11.23 B 12,242.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-C$0.37 Billion-504.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$31.46 B 34,469.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$10.94 B 11,926.71%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$12.70 B 13,857.90%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-C$84.32 Million-192.65%๐Ÿ‡บ๐Ÿ‡ธ USA